Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(10), P. 1055 - 1055
Published: Oct. 11, 2024
To
assess
the
incidence
and
temporal
trend
of
type
1
diabetes
(T1D)
diabetic
ketoacidosis
(DKA)
during
period
2014-2023
in
youths
aged
0-14
years
Trentino-Alto
Adige
region,
Italy.
Journal of Paediatrics and Child Health,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 20, 2025
ABSTRACT
Type
1
diabetes
(T1D)
has
two
pre‐symptomatic
phases
(stages
and
2)
with
progressive
destruction
of
beta
cells
which
have
been
identified
through
longitudinal
cohort
studies
in
recent
decades.
The
definition
T1D,
hyperglycaemia
that
may
or
not
be
symptomatic,
is
now
defined
as
stage
3.
There
growing
evidence
screening
for
stages
2
reduces
rates
diabetic
ketoacidosis
prevents
long‐term
complications.
These
can
by
the
presence
islet
autoantibodies
are
markers
autoimmune
cell
damage.
Furthermore,
genetic
risk
scores,
combine
a
variety
single
nucleotide
polymorphisms,
identify
people
at
high
future
T1D.
Thus,
they
provide
an
opportunity
to
select
high‐risk
individuals
autoantibody
testing.
Individuals
having
T1D
require
ongoing
monitoring
detect
need
insulin
replacement.
also
eligible
emerging
immunotherapies
delay
progression
This
review
article
explores
current
summarises
recommended
clinical
care
early‐stage
PubMed,
Journal Year:
2023,
Volume and Issue:
22, P. 1235 - 1263
Published: Jan. 1, 2023
Hesperidin
and
hesperetin,
two
flavonoids
with
potential
therapeutic
value,
have
been
extensively
studied
in
the
context
of
diabetes
management.
The
main
objective
this
research
is
to
ascertain
their
as
options
for
managing
its
complications.
present
study
utilized
a
systematic
review
methodology
comprehensively
explored
relevant
literature
from
databases,
including
PubMed,
Scopus,
Web
Science,
inception
until
July
2023.
summarized
outcomes
related
molecular,
cellular,
metabolic
effects
hesperidin
hesperetin
Hesperetin
exhibits
treatment
preventing
associated
complications
through
modulation
inflammatory
cytokine
release
expression
via
pathway
signaling
Toll-like
receptor/Myeloid
differentiation
factor
88/Nuclear
factor-kappa
B.
shows
promise
biomolecule
treating
diabetic
neuropathy,
primarily
activation
nuclear
erythroid
2-related
2
(Nrf-2),
an
antioxidant-response
element
signaling,
leading
neuroprotective
effects.
Both
compounds
demonstrated
ability
normalize
blood
glucose
levels
reduce
serum
liver
lipid
levels,
making
them
candidates
hypoglycemia
hypolipidemia
diabetes.
also
showed
benefits
against
nephropathy
by
suppressing
transforming
growth
factor-β1-integrin-linked
kinase-Akt
enhancing
renal
function.
Furthermore,
hesperidin's
antioxidant,
anti-inflammatory,
anti-depressant
conditions
expanded
applications.
This
provides
substantial
evidence
supporting
consideration
It
offers
exciting
possibilities
developing
novel,
cost-effective
enhance
management
patient
outcomes.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 15, 2024
Blood
glucose
monitoring
constitutes
a
pivotal
element
in
the
clinical
management
of
Type
1
diabetes
(T1D),
globally
escalating
metabolic
disorder.
Continuous
(CGM)
devices
have
demonstrated
efficacy
optimizing
glycemic
control,
mitigating
adverse
health
outcomes,
and
augmenting
overall
quality
life
for
individuals
afflicted
with
T1D.
Recent
progress
field
encompasses
refinement
electrochemical
sensors,
which
enhances
effectiveness
blood
monitoring.
This
empowers
patients
to
assume
greater
control
over
their
health,
alleviating
burdens
associated
condition,
contributing
alleviation
healthcare
system.
The
introduction
novel
medical
devices,
whether
derived
from
existing
prototypes
or
originating
as
innovative
creations,
necessitates
adherence
rigorous
approval
process
regulated
by
Food
Drug
Administration
(FDA).
Diverse
device
classifications,
stratified
risks,
dictate
distinct
pathways,
each
characterized
varying
timelines.
review
underscores
recent
advancements
primarily
based
on
sensors
elucidates
regulatory
journey
towards
FDA
approval.
advent
innovative,
non-invasive
holds
promise
maintaining
stringent
thereby
preventing
T1D-associated
comorbidities,
extending
expectancy
affected
individuals.
Archives of Endocrinology and Metabolism,
Journal Year:
2024,
Volume and Issue:
68
Published: Jan. 1, 2024
The
aim
of
this
study
was
to
assess
the
efficacy
and
safety
hybrid
closed-loop
(HCL)
systems
for
insulin
delivery
in
children
adolescents
with
type
1
diabetes
(T1D).
We
searched
Embase,
PubMed,
Cochrane
Library
randomized
controlled
trials
(RCTs)
published
until
March
2023
comparing
HCL
therapy
control
therapies
T1D.
computed
weighted
mean
differences
(WMDs)
continuous
outcomes
risk
ratios
(RRs)
95%
confidence
intervals
(CIs)
binary
endpoints.
[...]
Current Diabetes Reports,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 24, 2025
Abstract
Purpose
of
Review
The
prevalence
diabetes
is
rising
around
the
world
and
represents
an
important
public
health
concern.
Unlike
individual-level
risk
protective
factors
related
to
etiology
diabetes,
contextual
have
been
much
less
studied.
Identification
type
1
2
in
Organisation
for
Economic
Co-operation
Development
(OECD)
countries
may
help
professionals,
researchers,
policymakers
improve
surveillance,
develop
policies
programs,
allocate
funding.
Recent
Findings
Among
4,470
potential
articles,
48
were
included
this
review.
All
reviews
published
English
between
2005
2023
conducted
over
20
different
countries.
This
review
identified
ten
upstream
risk,
including
income,
employment,
education,
immigration,
race/ethnicity,
geography,
rural/urban
status,
built
environment,
environmental
pollution,
food
security/environment.
Summary
be
integrated
into
research,
surveillance
prevention
activities
promote
better
outcomes
people
at
or
living
with
OECD
Additional
research
needed
quantify
measures
associations
emerging
key
outcomes.
SAGE Open,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 1, 2025
Diabetes
prevalence
is
steadily
increasing
in
Europe.
This
study
aims
to
compare
diabetes
and
the
existence
of
related
socioeconomic
inequalities
between
19
European
countries.
Using
data
from
The
Social
Survey
(ESS),
there
were
31,178
participants
(53.06%
women)
aged
25+
years
Austria,
Belgium,
Czechia,
Denmark,
Finland,
France,
Germany,
Hungary,
Ireland,
Lithuania,
Netherlands,
Norway,
Poland,
Portugal,
Slovenia,
Spain,
Sweden,
Switzerland
United
Kingdom.
Education
level
employment
used
as
indicators
inequalities.
Logistic
regression
analyses
calculated
predict
by
controlling
for
age
gender.
Differences
effect
size
education
on
countries
then
further
examined.
Overall
Europe
was
reported
be
6.12%,
higher
Eastern
Southern
than
Northern
Western
Additionally,
men
had
a
risk
reporting
having
compared
women.
Employment
identified
protective
factor
against
development
across
all
regions.
Moreover,
individuals
with
tertiary
lower
most
regions
except
region.
Participants
levels
unemployed
ones
chance
diabetes.
found
some
Pediatric Diabetes,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Objective:
Adolescents
managing
type
1
diabetes
(T1D)
are
at
increased
risk
of
experiencing
eating
disorders
(EDs).
Identifying
factors
is
essential
to
develop
preventive
strategies.
This
study
examines
the
potential
mediation
value
self‐esteem
and
perfectionism
associated
with
EDs
in
relationship
between
sociocultural
attitudes
toward
appearance
related
a
sample
adolescents
T1D.
Methods:
Forty‐six
aged
12–17
years
diagnosed
T1D
participated
current
study.
Sociocultural
appearance,
EDs,
were
measured.
Multiple
simple
mediator
analyses
using
bootstrapping
method
bias‐corrected
confidence
estimates
conducted.
Results:
Our
results
show
that
problems
not
only
attitudes,
but
rather
these
last
two
variables
would
be
fully
mediated
by
perfectionism.
Conclusions:
A
high
degree
could
variable
when
developing
adolescents.
Perfectionism
its
self‐management
prominent
factor
may
help
design
interventions
developed
for
who
behaviors
potentially
conflict
eating.
The
clinical
implications
discussed.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 26, 2025
Post-translational
modifications
such
as
SUMOylation
are
crucial
for
the
functionality
and
signal
transduction
of
a
diverse
array
proteins.
Analogous
to
ubiquitination,
has
garnered
significant
attention
from
researchers
been
implicated
in
pathogenesis
various
human
diseases
recent
years,
cancer,
neurological
lesions,
cardiovascular
diseases,
diabetes
mellitus,
so
on.
The
diabetes,
particularly
type
1
2
closely
associated
with
immune
dysfunction,
which
constitutes
primary
focus
this
review.
This
review
will
elucidate
process
its
impact
on
mellitus
development
complications,
focusing
regulatory
effects
microenvironment.
article
summarizes
signaling
pathways
at
both
cellular
molecular
levels
that
these
processes.
Furthermore,
it
proposes
potential
new
targets
drug
aimed
prevention
treatment
based
insights
gained
process.